Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
Launched by CHANGHAI HOSPITAL · Apr 3, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying recurrent acute pancreatitis, a condition where the pancreas becomes inflamed repeatedly. The main aim of the study is to find out whether different treatments—like endoscopic procedures (a way to look inside the body using a camera), surgery, or conservative care (managing symptoms without surgery)—can help reduce the chances of having another episode of pancreatitis. Researchers also want to identify what factors might increase the risk of these recurrences.
If you have had recurrent acute pancreatitis and are interested in participating, you may be eligible for the study. The trial is open to all patients who meet the criteria, meaning you should be willing to provide consent to join. Participants will be monitored closely, and their health information will be recorded over time to help researchers understand the condition better. Overall, this study aims to improve treatment options and outcomes for those affected by recurrent acute pancreatitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with recurrent acute pancreatitis.
- Exclusion Criteria:
- • Unwilling or unable to provide consent.
About Changhai Hospital
Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Zhaoshen Li, M.D.
Study Chair
Changhai Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported